| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | CA2393586A1 Use of heat shock proteins |
| 06/28/2001 | CA2393500A1 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | CA2392873A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2392150A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | CA2389482A1 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
| 06/28/2001 | CA2384326A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | CA2384110A1 Treatment of viral infections using levovirintm |
| 06/28/2001 | CA2329676A1 Salmonella vaccine |
| 06/27/2001 | EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/27/2001 | EP1111053A2 Peptide fragment of the respiratory syncytial virus G protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/27/2001 | EP1111040A1 Infection of eukaryotic cells with viruses in vitro |
| 06/27/2001 | EP1110970A1 Anti-Procalcitonin antibody, their production and use |
| 06/27/2001 | EP1110957A1 Benzazole derivatives and their use as JNK modulators |
| 06/27/2001 | EP1110556A1 Preventives/remedies for multiple organ failure |
| 06/27/2001 | EP1110555A1 Antiadhesive agent for the pathogen flora of the skin |
| 06/27/2001 | EP1109911A2 Staphylococcus aureus genes and polypeptides |
| 06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 06/27/2001 | EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109893A2 Papillomaviruses, means for the detection thereof and therapy for diseases caused thereby |
| 06/27/2001 | EP1109831A2 Cyctotoxic peptides modified by bulky or lipophilic moieties |
| 06/27/2001 | EP1109829A1 Human latent transforming growth factor beta binding protein 3 |
| 06/27/2001 | EP1109827A2 Bioactive peptides |
| 06/27/2001 | EP1109820A1 Nocathiacin antibiotic derivatives prepared by microbial biotransformation |
| 06/27/2001 | EP1109818A1 Phosphoepoxides, method for making same and uses |
| 06/27/2001 | EP1109817A1 Phosphohalohydrins, method for making same and uses |
| 06/27/2001 | EP1109812A2 Pyrrolobenzodiazepines |
| 06/27/2001 | EP1109811A2 Pyrrolobenzodiazepines |
| 06/27/2001 | EP1109809A1 Pyrroloquinolines for treatment of obesity |
| 06/27/2001 | EP1109805A1 Inhibitors of bacterial nad synthetase |
| 06/27/2001 | EP1109804A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109803A1 Substituted imidazoles having cytokine inhibitory activity |
| 06/27/2001 | EP1109580A1 Methods for treating or preventing viral infections and associated diseases |
| 06/27/2001 | EP1109577A1 Multicomponent vaccines |
| 06/27/2001 | EP1109576A2 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
| 06/27/2001 | EP1109575A2 Live virus vaccines to protect primates from hiv-1 infection and disease |
| 06/27/2001 | EP1109574A1 Vaccine against sexually transmitted diseases |
| 06/27/2001 | EP1109566A1 Gcp |
| 06/27/2001 | EP1109565A1 Gabab1aa receptor |
| 06/27/2001 | EP1109562A1 Composite biocidal particles |
| 06/27/2001 | EP1109552A1 Novel dna-cleaving antitumor agents |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/27/2001 | EP1109454A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 06/27/2001 | EP0792167B1 Monofunctional and/or polyfunctional polylysine conjugates |
| 06/27/2001 | EP0727979B1 Novel composition |
| 06/27/2001 | EP0629131B1 Antigens protective against (echinococcus granulosus) infection and vaccines containing such antigens |
| 06/27/2001 | EP0572454B1 Process for the preparation of 29-desmethylrapamycin and its use as antifungal or immunosuppressant agent |
| 06/27/2001 | CN1301301A I (vibrio cholerae) vaccine candidates and method of their constructing |
| 06/27/2001 | CN1301268A 15-membered lactams ketolides with antibacterial activity |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301261A Production of furanones |
| 06/27/2001 | CN1301254A Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection |
| 06/27/2001 | CN1301180A Recombinant i(mycoplasma hyopneumoniae) vaccine |
| 06/27/2001 | CN1301175A Humanized antibodies that recognize verotoxin II and cell line producing same |
| 06/27/2001 | CN1301158A Compositions for the treatment of HIV and other viral infections |
| 06/27/2001 | CN1301157A Sustained release preparations |
| 06/27/2001 | CN1301147A Pharmaceutical compositions capable of being gelled |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1300850A Process for preparing VP2 protein from master host protective antigen (VP2) gene of infections burse disease virus (IBDV) and its gene engineering |
| 06/27/2001 | CN1300623A Chinese patent medicine |
| 06/27/2001 | CN1300608A Medicine-egg mixture for treating hepatitis B |
| 06/27/2001 | CN1300603A Medicine for treating nail ringworm and its preparing process |
| 06/27/2001 | CN1067559C Syrup for curing cold syndrome in women's lower abdomen, and method for preparing same |
| 06/27/2001 | CN1067549C Water soluble gossypol preparation and method therefor |
| 06/26/2001 | US6252116 Intermediates useful in a process for synthesizing COX-2 inhibitors |
| 06/26/2001 | US6252080 Herpes, cytomegalo virus |
| 06/26/2001 | US6252063 Salt forming using alkali metal compound |
| 06/26/2001 | US6252044 Riboflavin synthase polypeptide; for the controlled biosynthesis of riboflavin; for screening bactericides; for prevention of infection |
| 06/26/2001 | US6251953 Beta-carotene therapy of individuals having abnormal immunological and serological indices, and individuals having infections and diseases causing changes therein |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/26/2001 | US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 06/26/2001 | US6251891 Carbapenem derivatives |
| 06/26/2001 | US6251890 Treating or preventing bacterial infections in mammalian patients |
| 06/26/2001 | US6251870 Pharmaceutical composition for inhibiting growth of cancers |
| 06/26/2001 | US6251869 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 06/26/2001 | US6251868 Method for treating a human immunodeficiency virus infection |
| 06/26/2001 | US6251858 Derivatives of glycosylamine in which the oligosides are fixed on at least one molecule, matrix or particle |
| 06/26/2001 | US6251678 Mixture of virus particles, salt, histidine buffer and nonionic surfactant |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
| 06/26/2001 | US6251630 Polynucleotide encoding member of ribonuclease family of defined amino acid sequence; diagnosis; bacteriostats; bactericides; vaccines; treatment of otitis media, pneumonia, conjunctivitis, bacteremia, meningitis, sinusitis, and others |
| 06/26/2001 | US6251598 Methods for diagnosing sepsis |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251407 And adjuvant selected from manganese gluconate, calcium gluconate, zinc gluconate, calcium fructoheptonate, zinc glucoheptonate, or calcium glycerophosphate and an oily phase ester of ethoxylated fatty acids; immunostimulatory |
| 06/26/2001 | US6251406 Attenuated microorganism strains and their uses |
| 06/26/2001 | US6251405 Comprising borrelia burgdorferi outer surface protein (osp)c antigen and a second antigenic lipoprotein such as recombinant ospa, or streptococcus pneumoniae cell surface protein (pspa), both in same physio-chemical form |
| 06/26/2001 | US6251404 Collecting a sample of a naturally occurring isolated virus such as the iowa strain, and a naturally occuring strain that causes lesions in colostrum deprived piglets, treating to deactivate virus and admixing with carrier |
| 06/26/2001 | US6251403 Comprising a foreign dna encoding a cytokine inserted into a swinepox virus genome within a nonessential region and expressed in a host cell into which the virus is introduced; swinepox virus as a vector for delivery of vaccine antigens |
| 06/26/2001 | US6251399 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 06/26/2001 | US6251397 Purified polypeptides encoded by open reading frames (orf's) of a highly virulent strain of the virus as determined by its ability to induce lung lesions in 51.9% of colostrum-deprived piglets; vaccines |
| 06/26/2001 | US6251392 Polypeptides for cell targets |
| 06/26/2001 | US6251387 Topoisomerase I |
| 06/26/2001 | US6251383 Method for ex-vivo expansion of hematopoietic cells |
| 06/26/2001 | CA2078871C Cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis |
| 06/26/2001 | CA1341266C Combination of pyrimidine derivatives and antibacterial agents to induce and stimulate hair growth and reduce hair loss |
| 06/26/2001 | CA1341263C Recombinant fowlpox virus, heterologous protein expression vectors, and fowl vaccines derived from this virus |